← FDA Drug Approvals (Drugs@FDA)
CARBINOXAMINE MALEATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LEADING · Approved 2024-12-19
Drug application
- FDA Application #
ANDA215476- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBINOXAMINE MALEATE
- Generic name
- CARBINOXAMINE MALEATE
- Active ingredients
- CARBINOXAMINE MALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LEADING
- Manufacturer
- TRIPOINT THERAPEUTICS, LLC
- First approval
- 2024-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown